The Scientist

» drug development, evolution and immunology

Most Recent

image: Brains Before Brawn

Brains Before Brawn

By | March 16, 2016

A newly described horse-size relative of Tyrannosaurus rex may help settle the question of how massive carnivorous dinosaurs took shape throughout the eons.

0 Comments

image: Cannabis-Based Drug for Epilepsy

Cannabis-Based Drug for Epilepsy

By | March 14, 2016

A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder. 

0 Comments

image: Less Chewing, More Doing

Less Chewing, More Doing

By | March 11, 2016

Food processing in early hominid populations might have played a key role in human evolution by increasing net energy uptake, researchers show.

3 Comments

image: More Support for Allergen-Exposure Strategy

More Support for Allergen-Exposure Strategy

By | March 8, 2016

A second study finds evidence that feeding children peanuts could help prevent them from developing allergies to the legume later in life.

0 Comments

image: Viral Remnants Help Regulate Human Immunity

Viral Remnants Help Regulate Human Immunity

By | March 3, 2016

Endogenous retroviruses in the human genome can regulate genes involved in innate immune responses.

2 Comments

image: Amoebae Have Human-Like Immunity

Amoebae Have Human-Like Immunity

By | March 2, 2016

Dictyostelium discoideum produce extracellular nets that can kill bacteria, just as phagocytes in people and other higher animals do, according to a study.

0 Comments

image: Giant Virus Has CRISPR-like Immune Defense

Giant Virus Has CRISPR-like Immune Defense

By | March 2, 2016

The genome of a mimivirus strain resistant to a virophage has repeated phage sequences alongside nuclease- and helicase-coding sections.

1 Comment

image: Capsule Reviews

Capsule Reviews

By | March 1, 2016

Herding Hemingway's Cats, Hair: A Human History, Restless Creatures, and The Mind Club

0 Comments

image: Contributors

Contributors

By | March 1, 2016

Meet some of the people featured in the March 2016 issue of The Scientist.

0 Comments

image: Desperately Seeking Shut-Eye

Desperately Seeking Shut-Eye

By | March 1, 2016

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech